Combining Machine Learning with Next-Generation Sequencing creates Dermal Intelligence™: actionable information for payers, providers and patients to improve health outcomes and reduce healthcare spending.
(SAN DIEGO, CA – October 5, 2021) Mindera Corporation, developers of the groundbreaking Mind.Px™ – the first realization of truly personalized medicine in psoriasis – has changed its name to Mindera Health to better reflect the company’s data-driven precision medicine technology platform.
At the forefront of personalized medicine, the Mindera Health platform uses a patented, minimally invasive device to collect genetic biomarkers that correlate a patient’s transcriptome with that patient’s likely response to biologic treatments. By combining these genetic markers with machine learning, the Mindera Health platform helps physicians confidently choose what…